Literature DB >> 961606

Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction.

L H Opie, P Owen.   

Abstract

Glucose-insulin-potassium infusions were given to dogs for 6 hours, starting 30 minutes after ligation of the left anterior descending coronary artery. Effects on substrate arteriovenous differences, indexes of ischemic damage and other tissue metabolic changes were compared with changes in dogs with comparable ligations but no infusions. Glucose-insulin-potassium increased the arteriovenous difference of glucose, decreased that of free fatty acid and decreased the arterial free fatty acid/albumin molar ratio. Glucose-insulin-potassium accelerated the rate of fall of the epicardial S-T segment in the infarct zone and prevented the small rise in S-T segment found in the perlinfarct and nonischemic zones. Glucose-insulin-potassium increased the tissue content of glycogen in peripheral infarct, periinfarct and nonischemic zones; increased tissue potassium ion/sodium ion ratios in epicardial infarct zones and in the periinfarct zone; increased adenosine triphosphate in the endocardial infarct zone; decreased inorganic phosphate in the periinfarct and nonischemic zones and in the endocardial infarct zone; and increased lactate in the central infarct and nonischemic zones. The phosphate potential increased in the periinfarct and nonischemic zones. Thus, many glucose-insulin-potassium effects were greater in the peripheral infarct and especially the periinfarct zones. Although increased anaerobic metabolism with lactate production could not be excluded as a mode of action of glucose-insulin-potassium, estimated rates of anaerobic glycolysis were very low, suggesting that other effects such as increased aerobic glycolysis decreased extraction of free fatty acid by the heart, increased tissue glycogen or a "membrane" effect might be of major importance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961606     DOI: 10.1016/0002-9149(76)90173-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.

Authors:  P Zhu; L Lu; Y Xu; C Greyson; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-02       Impact factor: 4.733

Review 2.  Myocardial ischemia--metabolic pathways and implications of increased glycolysis.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

Authors:  E M Runnman; S T Lamp; J N Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

5.  The border zone of the early myocardial infarction in dogs; its characteristics and viability.

Authors:  T Sládek; J Filkuka; S Dolezel; J Vasků; B Hartmannová; J Trávnícková
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

6.  Effect of antilipolytic therapy on ST segment elevation during myocardial ischaemia in man.

Authors:  D C Russell; M F Oliver
Journal:  Br Heart J       Date:  1978-02

7.  Effects of acute hyperglycemia on myocardial glycolytic activity in humans.

Authors:  J A Wisneski; W C Stanley; R A Neese; E W Gertz
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

8.  Sustained effect of glucose-insulin-potassium on myocardial performance during regional ischemia. Role of free fatty acid and osmolality.

Authors:  S S Ahmed; C H Lee; H A Oldewurtel; T J Regan
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound: mechanism of action.

Authors:  S Datta; D K Das; R M Engelman; H Otani; J A Rousou; R H Breyer; J Klar
Journal:  Basic Res Cardiol       Date:  1989 Jan-Feb       Impact factor: 17.165

10.  Changes in myocardial substrate and energy metabolism by S-(4)-hydroxyphenylglycine and an N-(6)-derivative of adenosine.

Authors:  H Kahles; W Schäfer; T Lick; J Junggeburth; K Kochsiek
Journal:  Basic Res Cardiol       Date:  1986 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.